Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Trending Stock Alerts

OTLK - Buy Recommendation Issued On OTLK By BTIG

home / stock / otlk / otlk news

RSS
OTLK OTLK Quote OTLK Short OTLK News OTLK Articles OTLK Message Board
  • November, 29 2024 06:30 AM
  • |
  • KlickAnalytics
  • |
    • OTLK
    • OTLK Quote
    • OTLK Short
    • OTLK News
    • OTLK Articles
    • OTLK Message Board

2024-11-29 06:30:01 ET

  • BTIG analyst issues BUY recommendation for OTLK on November 29, 2024 11:02AM ET.
  • The previous analyst recommendation was Buy.
  • OTLK was trading at $1.7591 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 5 - Buy recommendations .

    • Historical Analyst Recommendations
    Latest 10 recommendations
    Full story available on KlickAnalytics.com

    Get Email and Text Alerts for (NASDAQ:OTLK)

    Get Email and Text Alerts for (NASDAQ:OTLK)

    News, Short Squeeze, Breakout and More Instantly...

    Tags
    • $OTLK
    Share This Post

    Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.

    Link your Twitter Account to Market Wire News

    When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

    Be alerted of any news about your stocks and see what other stocks are trending.

    Contact the Author

    Stock Information
    Get OTLK Alerts

    News, Short Squeeze, Breakout and More Instantly...

    Outlook Therapeutics Inc. Company Name:

    OTLK Stock Symbol:

    NASDAQ Market:

    Outlook Therapeutics Inc. Website:

    Outlook Therapeutics Inc. Logo

    Ad

    Trending Stock Alerts
    RECENT OTLK NEWS
    • OTLK - Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD

      First positive reimbursement decision worldwide for LYTENAVA™; First launch anticipated in H1 2025 LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) 40,000 ne...

    • OTLK - Outlook Therapeutics® Announces Executive Leadership Transition

      ISELIN, N.J., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year for LYTENAVA™ (bevacizumab gamma), the first ophthalmic formulation of...

    • OTLK - Buy Recommendation Issued On OTLK By BTIG

      2024-11-29 06:30:01 ET BTIG analyst issues BUY recommendation for OTLK on November 29, 2024 11:02AM ET. The previous analyst recommendation was Buy. OTLK was trading at $1.7591 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...

    •
    • Research
    • Stock Search
    • News Releases
    • Articles
    • Topics
    • Message Boards
    • Trending Stocks
    • Trending Feed
    • Trending Alerts
    • Watchlist
    • Short Information
    • Stock Wall
    • Link Twitter
    • Sign Up
    • Login
    • Contact

    Link your Twitter Account

    Link your Twitter Account to Market Wire News

    When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

    Be alerted of any news about your stocks and see what other stocks are trending.

    Trending Stock Alerts

    Trending Stock Alerts

    Our Next Stock Alert could be Coming in Minutes!

    Sign Up Today To Get Full Access To Our Next Stock Report!

    • Day Before Email and Text Notifications of New Alerts
    • Day of Email and Text Notifications
    • Trending Stocks, Watchlist and News Releases
    • Mobile App Notifications
    Trending Stock Alerts

    Get OTLK Alerts

    Get OTLK Alerts

    News, Short Squeeze, Breakout and More Instantly...

    Sign up or login to continue

    Sign up or login to continue.

    Forgot password?


    Mobile Number Subscribers

    Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

    How to Opt Out

    To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

    Mobile Support

    For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

    Disclaimer

    This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

    Advertise

    Brand your company, advertise your products or services with our ad programs.

    Advertise

    Research

    Stock Search

    News Releases

    Articles

    Message Boards

    Trending Stocks

    Short Information

    Stock Wall

    Members

    Log In

    Sign Up

    Stay Connected

    | X

    | Facebook

    | BlueSky

    | LinkedIn

    | Telegram

    | Discord

    Contact

    Privacy

    Terms of Service

    Disclaimer

    © 2024 Market Wire News 1